Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: A case report

International Journal of Gynecological Pathology

Volumn 25, Issue 2, 2006, Pages 173-175

  Botsis, Dimitris ^a   Koliopoulos, Carolina ^a,b   Kondi Pafitis, Agathi ^a   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Myxoid leiomyosarcoma; Tamoxifen; Uterine sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ABDOMINAL HYSTERECTOMY; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LONG TERM CARE; LYMPH NODE DISSECTION; MYXOID LEIOMYOSARCOMA; MYXOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TUMOR BIOPSY; UTERUS SARCOMA; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; PATHOLOGY; RISK FACTOR; UTERUS CANCER;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; LEIOMYOSARCOMA; RISK FACTORS; TAMOXIFEN; UTERINE NEOPLASMS;

EID: 33747183386     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000185407.93308.ce     Document Type: Article

References (18)

1. Bergman L, Beelen MLR, Gallee MPW, et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 2000;356:881-7.
2. Curtis RE, Freedman MD, Sherman ME, et al. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. J Natl Cancer Inst 2004;96:70-4.
3. Fotiou S, Hatjieleftheriou G, Kyrousis G, et al. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature. Anticancer Res 2000;20:2015-20.
4. Wickerham DL, Fisher B, Wolmark N, et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002;20:2758-60.
5. Carvalho FM, Carvalho JP, Motta EV, et al. Mullerian adenosarcoma of the uterus with sarcomatous overgrowth. Rev Hosp Clin Fac Med Sao Paulo Jan-Feb 2000;55:17-20.
6. Le Bouedec G, Auvray H, Cure H, et al. Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases. Rev Med Interne 2001;22:881-5.
7. Hubalek M, Ramoni A, Mueller-Holzner E, et al. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer. Gynecol Oncol 2004;95:264-6.
8. Martin-Loeches M, Rius J, Orti RM. Uterine sarcoma associated with tamoxifen use: case report. Eur J Gynecol Oncol 2003;2:202-3.
9. Rock JA, Thompson JD. Te Linde's Operative Gynecology. 8th ed. Philadelphia: Lippincott/Ravens; 1997.
10. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. In: Atlas of Tumor Pathology, 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1992:130-6.
11. Leitao MM, Soslow RA, Nonaka D, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004;101:1455-62.
12. Kunzel KE, Mills NZ, Muderpach LI, et al. Myxoid leiomyosarcoma of the uterus: case report. Gynecol Oncol 1993;48:277-80.
13. Silva EG, Tornos CS, Follen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int J Gynecol Pathol 1994;13:248-58.
14. Sabatini R, Di Fazio F, Loizzi P. Uterine leiomyosarcoma in postmenopausal woman treated with tamoxifen: case report. Eur J Gynaecol Oncol 1999;20:327-8.
15. Kennedy MM, Baigrie CF, Manek S. Tamoxifen and the endometrium: a review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Int J Gynecol Pathol 1999;18:130-7.
16. McCluggage WG, Varma M, Weir P, et al. Uterine leiomyosarcoma in patient receiving tamoxifen therapy. Acta Obstet Gynecol Scand 1996;75:593-5.
17. Gillet D. Leiomyosarcoma of the uterus in a woman taking adjuvant tamoxifen therapy. Med J Aust 1995;163:160-1.
18. Chang E, Shim SI. Myxoid Leiomyosarcoma of the uterus: a case report and review of the literature. J Korean Med Sci 1998;13:559-62.